Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
2.040
+0.060 (3.03%)
At close: Dec 5, 2025, 4:00 PM EST
2.050
+0.010 (0.49%)
After-hours: Dec 5, 2025, 7:55 PM EST
Fractyl Health Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Fractyl Health stock ranges from a low of $3.60 to a high of $10. The average analyst price target of $7.40 forecasts a 262.75% increase in the stock price over the next year.
Price Target: $7.40 (+262.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Fractyl Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +292.16% | Dec 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +292.16% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +292.16% | Sep 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +341.18% | Sep 15, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $3.6 | Strong Buy | Initiates | $3.6 | +76.47% | Aug 28, 2025 |
Financial Forecast
Revenue This Year
n/a
from 93.00K
Revenue Next Year
n/a
EPS This Year
-1.66
from -1.62
EPS Next Year
-0.72
from -1.66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.37 | -0.64 | ||||
| Avg | -1.66 | -0.72 | ||||
| Low | -1.89 | -0.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.